Catheter Ablation in Atrial Fibrillation Patients With HFpEF (STABLE-SR IV Trial)
Status:
Recruiting
Trial end date:
2026-11-01
Target enrollment:
Participant gender:
Summary
To investigate whether RFCA is superior to AADs in AF patients with HFpEF on the basis of
optimized anti-heart-failure drug therapy regarding their longterm clinical outcomes.
Phase:
N/A
Details
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University